Pembrolizumab in microsatellite instability high or mismatch repair deficient cancers: updated analysis from the phase II KEYNOTE-158 study

Authors: Michele Maio, Paolo A. Ascierto, L. V. Manzyuk, Daniel Motola‐Kuba, Nicolas Penel, Philippe A. Cassier, Giovanni M. Bariani, A. De Jesus Acosta, Toshihiko Doi, Federico Longo, Wilson H. Miller, Do‐Youn Oh, Maya Gottfried, Lei Xu, Fan Jin, Kevin Norwood, Aurélien Marabelle - Annals of Oncology 2022 cited by 445